Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $587.1 million.

  • Health Catalyst's Liabilities and Shareholders Equity fell 2778.7% to $587.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 179.49%. This contributed to the annual value of $858.9 million for FY2024, which is 2238.7% up from last year.
  • As of Q3 2025, Health Catalyst's Liabilities and Shareholders Equity stood at $587.1 million, which was down 2778.7% from $616.2 million recorded in Q2 2025.
  • Health Catalyst's Liabilities and Shareholders Equity's 5-year high stood at $891.5 million during Q1 2025, with a 5-year trough of $563.0 million in Q2 2021.
  • For the 5-year period, Health Catalyst's Liabilities and Shareholders Equity averaged around $737.9 million, with its median value being $752.3 million (2022).
  • Per our database at Business Quant, Health Catalyst's Liabilities and Shareholders Equity surged by 8500.6% in 2021 and then tumbled by 2778.7% in 2025.
  • Over the past 5 years, Health Catalyst's Liabilities and Shareholders Equity (Quarter) stood at $832.1 million in 2021, then fell by 9.59% to $752.3 million in 2022, then decreased by 6.71% to $701.8 million in 2023, then grew by 22.39% to $858.9 million in 2024, then tumbled by 31.64% to $587.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $587.1 million in Q3 2025, compared to $616.2 million in Q2 2025 and $891.5 million in Q1 2025.